Cosmo Pharmaceuticals NV banner

Cosmo Pharmaceuticals NV
F:C43

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
F:C43
Watchlist
Price: 68.7 EUR 0.88% Market Closed
Market Cap: €1.1B

Wall St Price Targets

C43 Price Targets Summary
Cosmo Pharmaceuticals NV

Wall Street analysts forecast C43 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for C43 is 145.75 EUR with a low forecast of 113.17 EUR and a high forecast of 186.39 EUR.

Lowest Forecast
Price Target
113.17 EUR
65% Upside
Average Forecast
Price Target
145.75 EUR
112% Upside
Highest Forecast
Price Target
186.39 EUR
171% Upside
Cosmo Pharmaceuticals NV Competitors:
Price Targets
LE
Lands End Inc
68% Upside

Revenue
Forecast

8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 38%.

Gross Profit
Forecast

7% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is 44%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C43's stock price target?
Price Target
145.75 EUR

According to Wall Street analysts, the average 1-year price target for C43 is 145.75 EUR with a low forecast of 113.17 EUR and a high forecast of 186.39 EUR.

What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 38%.

What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is 44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett